Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TRIM49C (tripartite motif-containing protein 49C) is a protein coded by the *TRIM49C* gene, part of the TRIM family of proteins characterized by a RING domain, one B-box type 2 domain, and a coiled-coil region. These domains confer E3 ubiquitin ligase activity, allowing it to tag target proteins for degradation or regulate their cellular fate via ubiquitination. TRIM49C is predicted to participate in regulation of gene expression and innate immune response, and is localized to the cytoplasm. There are currently no publications describing its direct role in diseases, its therapeutic targeting, or known small molecule or biologic interactions[3][4]. The TRIM protein family has been highlighted for the regulatory potential in cell signaling and immunity, where other family members are being explored as therapeutic targets, but TRIM49C itself is not known to be clinically targeted[1][2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tripartite motif-containing protein 49C (TRIM49C).